Preventive Therapy of Migraine.

Author: SchwedtTodd J

Paper Details 
Original Abstract of the Article :
PURPOSE OF REVIEW: This article reviews the preventive therapy of migraine, including indications, strategies for use, and available treatments. RECENT FINDINGS: Lifestyle modifications and migraine trigger avoidance are recommended as preventive measures for all individuals with migraine. The deci...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/30074549

データ提供:米国国立医学図書館(NLM)

Navigating the Desert of Migraine Prevention

Migraine, like a persistent desert wind, can disrupt our lives, leaving us feeling lost and overwhelmed. This research explores the landscape of migraine prevention, presenting a comprehensive overview of current therapies and strategies. It emphasizes the importance of lifestyle modifications and trigger avoidance as foundational steps, while also highlighting the growing range of preventive therapies, including medications, nutraceuticals, neurostimulation, and behavioral therapy. The research provides a roadmap for navigating the diverse options available, helping patients and clinicians make informed decisions based on individual needs and preferences.

A Multifaceted Approach to Migraine Prevention

The research emphasizes that migraine prevention is not a one-size-fits-all approach. It's like finding the right shade in the desert – a combination of strategies is often needed to find relief. The authors highlight a variety of effective treatments, including amitriptyline, beta-blockers, biofeedback, candesartan, coenzyme Q10, cognitive-behavioral therapy, magnesium citrate, onabotulinumtoxinA (for chronic migraine), relaxation therapy, riboflavin, and topiramate. The approval of erenumab, a calcitonin gene-related peptide (CGRP) receptor monoclonal antibody, in 2018 represents a significant milestone in migraine prevention.

Empowering Patients to Take Control

This research underscores the importance of patient education and shared decision-making in migraine management. It's like learning to read the desert's signs – understanding your triggers, treatment options, and potential side effects empowers you to take control of your health. Patients must be counseled on the importance of adhering to their treatment plan, as consistency is key to minimizing the impact of migraine attacks.

Dr. Camel's Conclusion

This research provides a comprehensive guide to migraine prevention, emphasizing the need for personalized approaches that consider individual preferences and the evolving landscape of treatment options. It reminds us that with the right knowledge and tools, we can navigate the desert of migraine and find relief, allowing us to live a more fulfilling life.

Date :
  1. Date Completed 2019-07-25
  2. Date Revised 2019-07-25
Further Info :

Pubmed ID

30074549

DOI: Digital Object Identifier

00132979-201808000-00008

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.